Initial Study of Insomnia/Nightmare Group Treatment for Posttraumatic Stress Disorder (PTSD)
16 mars 2011 uppdaterad av: Michael E. DeBakey VA Medical Center
An Investigation Of The Effectiveness of a Cognitive Behavioral Group Treatment Addressing Insomnia and Nightmares In Veterans With PTSD
Many combat Veterans suffer from posttraumatic stress disorder (PTSD), an anxiety disorder that develops after an extremely stressful event or events.
PTSD is associated with problems falling asleep or staying asleep.
Veterans with PTSD also commonly have nightmares from stressful experiences.
These symptoms can cause problems in daily life.
Behavioral treatments that do not involve taking medication have been shown to help improve problems related to sleep and nightmares.
However, very few of these treatments address both sleep problems and nightmares at the same time, even though many people suffer from both problems.
The purpose of this study is to examine the effectiveness of a combined treatment for sleep problems and nightmares in Veterans suffering from combat-related PTSD that is presented in a group format.
The investigators hypothesize that the completion of this treatment will lead to increases in sleep quality and decreases in the frequency and severity of nightmares as measured by standard questionnaires.
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Förväntat)
30
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- Michael E. DeBakey VA Medical Center
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Must be enrolled in the Michael E. DeBakey VAMC Trauma Recovery Program and qualify for a diagnosis of combat-related PTSD related to service in Vietnam-era conflicts as measured by responses to the Clinician-Administered PTSD Scale (CAPS) and total score ≥ 50 on the Posttraumatic Stress Disorder Checklist Stressor Specific Version (PCL-S)
- Have a clinically significant sleep problem as measured by a total score > 5 on the Pittsburgh Sleep Quality Index (PSQI)
- Have a repetitive trauma-related nightmare at least once per week on average, as measured by the Nightmare Frequency Questionnaire (NFQ), and which significantly impairs sleep as measured by response ≥ 2 on question 1a of the Nightmare Effects Survey (NES)
- Be stable on current regimen of psychotropic medication (i.e., no changes to medications and/or dosages) if applicable
- Must sign consent to be audio-recorded as part of the course of the treatment
Exclusion Criteria:
- Current substance dependence
- Planned or ongoing participation in Prolonged Exposure or Cognitive Processing Therapy during treatment participation
- Organic psychosis
- Bipolar I disorder
- Epilepsy
- Currently on benzodiazepine or hypnotic medication to treat sleep
- Currently take prazosin
- Indication of undiagnosed sleep apnea defined as score ≥ .5 across items 1, 5, and 8 of the Multivariable Apnea Risk Index
- Uncontrolled sleep apnea
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Group Intervention
Subjects randomly assigned to this arm of the study will receive the 9-week insomnia and nightmare intervention group once per week for 90 minutes in addition to continuing treatment as usual with medical and mental health providers.
|
Group based cognitive-behavioral therapy meeting weekly for 90 minutes over the course of 9 weeks.
Utilizes stimulus control, sleep scheduling, and progressive muscle relaxation to address symptoms of insomnia.
Imagery rehearsal and rescripting are used to address nightmare symptoms.
|
|
Inget ingripande: Treatment as Usual
This group is randomly assigned to receive only treatment as usual and does not receive the active intervention of the insomnia and nightmare group treatment.
This treatment will be made available to these members once the study is completed
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pittsburgh Sleep Quality Index, with Addendum for PTSD
Tidsram: baseline and 20 weeks
|
Self report measure of sleep quality and degree to which sleep is affected by PTSD.
|
baseline and 20 weeks
|
|
Nightmare Effects Survey
Tidsram: baseline and 20 weeks
|
Self-report assessment of psychosocial impairment resulting from experience of nightmares
|
baseline and 20 weeks
|
|
Posttraumatic Stress Disorder Checklist- Stressor Specific Version
Tidsram: baseline and 20 weeks
|
Self-report measure of Posttraumatic Stress Disorder symptoms.
|
baseline and 20 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinician Administered PTSD Scale
Tidsram: baseline and 10 weeks
|
Structured Clinical Interview focused on symptoms of Posttraumatic Stress Disorder
|
baseline and 10 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Robert D Beck, Ph.D, Michael E. DeBakey VA Medical Center
- Huvudutredare: Whitney L Brown, Psy.D, Michael E. DeBakey VA Medical Center
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 mars 2011
Primärt slutförande (Förväntat)
1 augusti 2011
Avslutad studie (Förväntat)
1 augusti 2011
Studieregistreringsdatum
Först inskickad
9 mars 2011
Först inskickad som uppfyllde QC-kriterierna
11 mars 2011
Första postat (Uppskatta)
14 mars 2011
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
17 mars 2011
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
16 mars 2011
Senast verifierad
1 mars 2011
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- H-28115
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .